KNSAKiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A
$77.09
$0.78
(1.02%)
Today
·Closed $77.09
$0.00
(0.00%)
After Hours
EarningsOct 27
Mkt Cap$5.95B
Vol378,744.00
About KNSA
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Fundamentals
Mkt Cap
$5.95B
Volume
-
52W High
$82.94
52W Low
$35.20
PE Ratio
78.38
Avg. Volume
571,665.82
EPS (Annual)
$0.7471
P/B
9.19
Rev/Employee
$1,851,267.76
Earnings
Oct 27
54
Neutral Sentiment
How do you feel about KNSA?
Massimino
$KNSA I may regret this lol but I sold 20% of my position as it was getting too big!Still super bullish and hold most of it with $28AVERAGE
Casperthecat
$KNSA this company is crazy they are a management nightmare. Whoever invest in this company or buyout this company need to look at how many sales reps they have fired in the last 6 mo. They are definitely going to get sued. Huge liability.
FiveMinute
🟡 $KNSA sitting right on the EMA20 ($77.33) after a strong run — clean pullback, RSI neutral at 52.7, nothing overbought. Structure still fully bullish above EMA50/200. Biotech name so it can gap on any FDA/trial news, but technically this looks like healthy digestion, not a breakdown. Anyone else watching this one? 👀